Growth factor signaling induces metastasis genes in transformed cells: Molecular connection between Akt kinase and osteopontin in breast cancer

Molecular and Cellular Biology

Volumn 23, Issue 18, 2003, Pages 6507-6519

  Zhang, Guoxin ^a,c   He, Bin ^a   Weber, Georg F ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; GROWTH FACTOR; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; BENIGN TUMOR; BREAST CANCER; CANCER INVASION; CELL CYCLE; CELL DIVISION; CELL IMMORTALIZATION; CELL MOTION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSFECTION; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TRANSFORMED; CELL MOVEMENT; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; OSTEOPONTIN; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA; HESPERIA COMMA BOREALIS;

EID: 0041689974     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.18.6507-6519.2003     Document Type: Article

References (56)

1. Adler, B., G. F. Weber, and H. Cantor. 1998. Activation of T-cells by superantigen: cytokine production but not apoptosis depends on MEK-1 activity. Eur. J. Immunol. 28:3749-3754.
2. Atkins, K. B., R. U. Simpson, and M. J. Somerman. 1997. Stimulation of osteopontin mRNA expression in HL-60 cells is independent of differentiation. Arch. Biochem. Biophys. 343:157-163.
3. Barcellos-Hoff, M. H., and S. A. Ravani. 2000. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 60:1254-1260.
4. Barraclough, R., H. J. Chen, B. R. Davies, M. P. Davies, Y. Ke, B. H. Lloyd, A. Oates, and P. S. Rudland. 1998. Use of DNA transfer in the induction of metastasis in experimental mammary systems. Biochem. Soc. Symp. 63:273-294.
5. Biswas, D. K., A. P. Cruz, E. Gansberger, and A. B. Pardee. 2000. Epidermal growth factor-induced nuclear factor κB activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc. Natl. Acad. Sci. USA 97:8542-8547.
6. Brockhoff, G., P. Heiss, J. Schlegel, F. Hofstaedter, and R. Knuechel. 2001. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells. Cytometry 44:338-348.
7. Carles-Kinch, K., K. E. Kilpatrick, J. C. Stewart, and M. S. Kinch. 2002. Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior. Cancer Res. 62:2840-2847.
8. Chackalaparampil, I., A. Peri, M. Nemir, M. D. Mckee, P. H. Lin, B. B. Mukherjee, and A. B. Mukherjee. 1996. Cells in vivo and in vitro from osteopetrotic mice homozygous for c-src disruption show suppression of synthesis of osteopontin, a multifunctional extracellular matrix protein. Oncogene 12:1457-1467.
9. Chambers, A. F., E. I. Behrend, S. M. Wilson, and D. T. Denhardt. 1992. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Anticancer Res. 12:43-48.
10. Chambers, A. F., and A. B. Tuck. 1993. Ras-responsive genes and tumor metastasis. Crit. Rev. Oncog. 4:95-114.
11. Chen, H., Y. Ke, A. J. Oates, R. Barraclough, and P. S. Rudland. 1997. Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line. Oncogene 14:1581-1588.
12. Cheng, H.-L., M. Steinway, C. L. Delaney, T. F. Franke, and E. L. Feldman. 2000. IGF-I promotes Schwann cell motility and survival via action of Akt. Mol. Cell. Endocrinol. 170:211-215.
13. Craig, A. M., G. T. Bowden, A. F. Chambers, M. A. Spearman, A. H. Greenberg, J. A. Wright, M. McLeod, and D. T. Denhardt. 1990. Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts. Int. J. Cancer 46:133-137.
14. Craig, A. M., M. Nemir, B. B. Mukherjee, A. F. Chambers, and D. T. Denhardt. 1988. Identification of the major phosphoprotein secreted by many rodent cell lines as 2ar/osteopontin: enhanced expression in H-ras-transformed 3T3 cells. Biochem. Biophys. Res. Commun. 157:166-173.
15. Denhardt, D. T., C. M. Giachelli, and S. R. Rittling. 2001. Role of osteopontin in cellular signaling and toxicant injury. Annu. Rev. Pharmacol. Toxicol. 41:723-749.
16. ARF tumor suppressor. Mol. Cell. Biol. 20:273-285.
17. Dunn, S. E., J. V. Torres, J. S. Oh, D. M. Cykert, and J. C. Barrett. 2001. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase. Cancer Res. 61:1367-1374.
18. Eder, A. M., L. Dominguez, T. F. Franke, and J. D. Ashwell. 1998. Phosphoinositide 3-kinase regulation of T cell receptor-mediated interleukin-2 gene expression in normal T cells. J. Biol. Chem. 273:28025-28031.
19. El-Tanani, M., R. Barraclough, M. C. Wilkinson, and P. S. Rudland. 2001. Metastasis-inducing DNA regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4. Cancer Res. 61:5619-5629.
20. El-Tanani, M. K., R. Barraclough, M. C. Wilkinson, and P. S. Rudland. 2001. Regulatory region of metastasis-inducing DNA is the binding site for T cell factor-4. Oncogene 20:1793-1797.
21. Giap, A. Q., A. Tarnawski, N. T. Hoa, V. Akotia, and Y. Ma. 2002. NSAID inhibition of RGM1 gastric monolayer wound re-epithelialization: comparison of selective Cox-2 versus non-selective Cox inhibitors. Life Sci. 70:3029-3037.
22. Gunthert, U., M. Hofmann, W. Rudy, S. Reber, M. Zoller, I. Haussmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24.
23. Guo, X., Y. P. Zhang, D. A. Mitchell, D. T. Denhardt, and A. F. Chambers. 1995. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell. Mol. Cell. Biol. 15:476-487.
24. Hermanto, U., C. S. Zong, and L. H. Wang. 2001. ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth. Oncogene 20:7551-7562.
25. James, N. H., J. Ashby, and R. A. Roberts. 1995. Enhanced hepatocyte colony growth in soft agar after in vivo treatment with a genotoxic carcinogen: a potential assay for hepatocarcinogens? Cancer Lett. 93:121-128.
26. Jerry, D. J., M. A. Ozbun, F. S. Kittrell, D. P. Lane, D. Medina, and J. S. Butel. 1993. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. Cancer Res. 53:3374-3381.
27. Katz, R. W., S. Y. Teng, S. Thomas, and R. Landesberg. 2002. Paracrine activation of extracellular signal-regulated kinase in a simple in vitro model of wounded osteoblasts. Bone 31:288-295.
28. Kitaura, J., K. Asai, M. Maeda-Yamamoto, Y. Kawakami, U. Kikkawa, and T. Kawakami. 2000. Akt-dependent cytokine production in mast cells. J. Exp. Med. 192:729-740.
29. Kittrell, F. S., C. J. Oborn, and D. Medina. 1992. Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro. Cancer Res. 52:1924-1932.
30. Kuppumbatti, Y. S., B. Rexer, S. Nakajo, K. Nakaya, and R. Mira-y-Lopez. 2001. CRBP suppresses breast cancer cell survival and anchorage-independent growth. Oncogene 20:7413-7419.
31. Kip1 and cyclin D1 through multiple signaling pathways. Cancer Res. 61:6583-6591.
32. Li, W., J. Zhang, L. Flechner, T. Hyun, A. Yam, T. F. Franke, and J. H. Pierce. 1999. Protein kinase C-α overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal. Oncogene 18: 6564-6572.
33. Lim, S. J., G. Lopez-Berestein, M. C. Hung, R. Lupu, and A. M. Tari. 2000. Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells. Oncogene 19:6271-6276.
34. Malyankar, U. M., M. Almeida, R. J. Johnson, R. H. Pichler, and C. M. Giachelli. 1997. Osteopontin regulation in cultured rat renal epithelial cells. Kidney Int. 51:1766-1773.
35. Moasser, M. M., A. Basso, S. D. Averbuch, and N. Rosen. 2001. The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. Cancer Res. 61: 7184-7188.
36. Nakanishi, K., M. Sakamoto, J. Yasuda, M. Takamura, N. Fujita, T. Tsuruo, S. Todo, and S. Hirohashi. 2002. Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer. Cancer Res. 62:2971-2975.
37. Nose, K., H. Saito, and T. Kuroki. 1990. Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in rastransformed cells. Cell Growth Differ. 1:511-518.
38. Oates, A. J., R. Barraclough, and P. S. Rudland. 1996. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 13:97-104.
39. Ozbun, M. A., D. J. Jerry, F. S. Kittrell, D. Medina, and J. S. Butel. 1993. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro. Cancer Res. 53:1646-1652.
40. Park, B.-K., X. Zeng, and R. Glazer. 2001. Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res. 61:7647-7653.
41. Pianetti, S., M. Arsura, R. Romieu-Mourez, R. J. Coffey, and G. E. Sonenshein. 2001. Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN. Oncogene 20:1287-1299.
42. Rudland, P. S., A. Platt-Higgins, M. El-Tanani, S. De Silva Rudland, R. Barraclough, J. H. Winstanley, R. Howitt, and C. R. West. 2002. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res. 62:3417-3427.
43. Ryo, A., Y. C. Liou, G. Wulf, M. Nakamura, S. W. Lee, and K. P. Lu. 2002. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell. Biol. 22:5281-5295.
44. Seiter, S., R. Arch, S. Reber, D. Komitowski, M. Hofmann, H. Ponta, P. Herrlich, S. Matzku, and M. Zoller. 1993. Prevention of tumor metastasis formation by anti-variant CD44. J. Exp. Med. 177:443-455.
45. Singhal, H., D. S. Bautista, K. S. Tonkin, F. P. O'Malley, A. B. Tuck, A. F. Chambers, and J. F. Harris. 1997. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased surviral. Clin. Cancer Res. 3:605-611.
46. Sun, M., J. E. Paciga, R. I. Feldman, A. Yuan, D. Coppola, Y. Y. Lu, S. A. Shelley, S. V. Nicosia, and J. Q. Cheng. 2001. Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor α (ERα) via interaction between ERα and PI3K. Cancer Res. 61:5985-5991.
47. Sung, V., C. Gilles, A. Murray, R. Clarke, A. D. Aaron, N. Azumi, and E. W. Thompson. 1998. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype. Exp. Cell Res. 241:273-284.
48. Tanno, S., S. Tanno, Y. Mitsuuchi, A. Altomare, G.-H. Xiao, and J. R. Testa. 2001. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res. 61:589-593.
49. Tsai, E. M., S. C. Wang, J. N. Lee, and M. C. Hung. 2001. Akt activation by estrogen in estrogen receptor-negative breast cancer cells. Cancer Res. 61: 8390-8392.
50. Tuck, A. B., D. M. Arsenault, F. P. O'Malley, C. Hota, M. C. Ling, S. M. Wilson, and A. F. Chambers. 1999. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene 18:4237-4246.
51. Urquidi, V., D. Sloan, K. Kawai, D. Agarwal, A. C. Woodman, D. Tarin, and S. Goodison. 2002. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin. Cancer Res. 8:61-74.
52. Weber, G. F. 2001. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim. Biophys. Acta 1552:61-85.
53. Weber, G. F., and S, Ashkar. 2000. Stress response genes - the genes that make cancer metastasize. J. Mol. Med. 78:404-408.
54. Weber, G. F., R. Bronson, J. Ilagan, H. Cantor, R. Schmitz, and T. W. Mak. 2002. Absence of CD44 prevents sarcoma metastasis. Cancer Res. 62:2281-2286.
55. Zhang, R. D., I. J. Fidler, and J. E. Price. 1991. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 11:204-215.
56. Zhou, B. P., Y. Liao, W. Xia, B. Spohn, M. H. Lee, and M. C. Hung. 2001. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3:245-252.